Nuvectis Pharma, Inc. Quarterly Current Ratio in % from Q3 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Nuvectis Pharma, Inc. quarterly Current Ratio history and growth rate from Q3 2022 to Q3 2024.
Nuvectis Pharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 301 %, a 27.1% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	301	-112	-27.1%	Sep 30, 2024
Q2 2024	331	-119	-26.4%	Jun 30, 2024
Q1 2024	377	-59.8	-13.7%	Mar 31, 2024
Q4 2023	391	-76.8	-16.4%	Dec 31, 2023
Q3 2023	413	-79.5	-16.1%	Sep 30, 2023
Q2 2023	450			Jun 30, 2023
Q1 2023	436			Mar 31, 2023
Q4 2022	468			Dec 31, 2022
Q3 2022	492			Sep 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.